Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
Olivier Peyrony(Assistance Publique – Hôpitaux de Paris), Jean-Paul Fontaine(Hôpital Saint-Louis), Camille Gerlier(Hôpital Saint Joseph), Sylvie Chevret(Saint Louis University Hospital), Élie Azoulay(Hôpital Saint-Louis), Sami Ellouze(HiFiBiO Therapeutics (France)), Léa Legay(Hôpital Saint-Louis), Imola Barla(Hôpital Saint-Louis)
Cited by 24
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723